KR100226310B1 - 인돌린-2-온 유도체 - Google Patents
인돌린-2-온 유도체 Download PDFInfo
- Publication number
- KR100226310B1 KR100226310B1 KR1019950703395A KR19950703395A KR100226310B1 KR 100226310 B1 KR100226310 B1 KR 100226310B1 KR 1019950703395 A KR1019950703395 A KR 1019950703395A KR 19950703395 A KR19950703395 A KR 19950703395A KR 100226310 B1 KR100226310 B1 KR 100226310B1
- Authority
- KR
- South Korea
- Prior art keywords
- group
- substituted
- unsubstituted
- indolin
- methylphenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP93-67297 | 1993-02-17 | ||
| JP6729793 | 1993-02-17 | ||
| JP93-167262 | 1993-05-31 | ||
| JP16726293 | 1993-05-31 | ||
| PCT/JP1994/000235 WO1994019322A1 (en) | 1993-02-17 | 1994-02-17 | Indolin-2-one derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR960701011A KR960701011A (ko) | 1996-02-24 |
| KR100226310B1 true KR100226310B1 (ko) | 1999-10-15 |
Family
ID=26408486
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019950703395A KR100226310B1 (ko) | 1993-02-17 | 1994-02-17 | 인돌린-2-온 유도체 |
Country Status (19)
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
| US6878728B1 (en) | 1999-06-11 | 2005-04-12 | Vertex Pharmaceutical Incorporated | Inhibitors of aspartyl protease |
| IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| US5783701A (en) | 1992-09-08 | 1998-07-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
| US5723490A (en) * | 1992-09-08 | 1998-03-03 | Vertex Pharmaceuticals Incorporated | THF-containing sulfonamide inhibitors of aspartyl protease |
| KR100235161B1 (ko) * | 1993-11-26 | 2001-11-22 | 찌바따 이찌로, 다나까 도시오 | 2-옥소인돌린 유도체 |
| DE69512220T2 (de) * | 1994-03-07 | 2000-03-16 | Vertex Pharma | Sulfonamidderivate als aspartylprotease-inhibitoren |
| US5691372A (en) * | 1995-04-19 | 1997-11-25 | Vertex Pharmaceuticals Incorporated | Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease |
| US6004957A (en) * | 1995-06-07 | 1999-12-21 | Vertex Pharmaceuticals, Incorporated | Sulfonamide inhibitors of aspartyl protease |
| AU2233097A (en) * | 1996-03-11 | 1997-10-01 | Chugai Seiyaku Kabushiki Kaisha | Process for the preparation of optically active indole compounds |
| WO1998002419A1 (fr) * | 1996-07-12 | 1998-01-22 | Chugai Seiyaku Kabushiki Kaisha | Inhibiteurs de proliferation de cellules cancereuses |
| US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
| BR9912169A (pt) | 1998-06-19 | 2001-04-10 | Vertex Pharma | Inibidores de sulfonamida de protease de aspartil |
| ATE285769T1 (de) * | 1998-12-04 | 2005-01-15 | Neurosearch As | Verwendung von isatinderivaten als ionenkanalaktivierende mittel |
| US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| JP4058243B2 (ja) * | 1999-01-29 | 2008-03-05 | 中外製薬株式会社 | 軟骨形成促進剤およびインドリン−２−オン誘導体 |
| ATE425142T1 (de) * | 1999-04-23 | 2009-03-15 | Vertex Pharma | Inhibitoren von c-jun n-terminal kinasen (jnk) |
| US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| WO2001038322A1 (en) | 1999-11-23 | 2001-05-31 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| US20030187054A1 (en) * | 2000-03-10 | 2003-10-02 | Shunsuke Nagao | Preparations for chondrogenesis |
| US7612065B2 (en) | 2000-04-21 | 2009-11-03 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-JUN N-terminal kinases (JNK) |
| WO2001098269A2 (en) * | 2000-06-21 | 2001-12-27 | Bristol-Myers Squibb Pharma Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| US6638950B2 (en) | 2000-06-21 | 2003-10-28 | Bristol-Myers Squibb Pharma Company | Piperidine amides as modulators of chemokine receptor activity |
| JP4897221B2 (ja) | 2002-12-20 | 2012-03-14 | チバ ホールディング インコーポレーテッド | アミン類の合成及びその合成のための中間体 |
| CN1324009C (zh) * | 2003-01-30 | 2007-07-04 | 普文英 | 化合物1－n－甲氧基－2－氧－吲哚－3－乙酰胺及其药物用途 |
| WO2008027692A2 (en) * | 2006-08-02 | 2008-03-06 | Abu-Ageel Nayef M | Led-based illumination system |
| US20090050905A1 (en) * | 2007-08-20 | 2009-02-26 | Abu-Ageel Nayef M | Highly Efficient Light-Emitting Diode |
| US20100202129A1 (en) * | 2009-01-21 | 2010-08-12 | Abu-Ageel Nayef M | Illumination system utilizing wavelength conversion materials and light recycling |
| US8987310B2 (en) | 2009-10-30 | 2015-03-24 | Merck Sharp & Dohme Corp. | Heterocycle amide T-type calcium channel antagonists |
| CN102516153B (zh) * | 2011-12-14 | 2014-03-12 | 南京工业大学 | 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用 |
| PL3071206T3 (pl) | 2013-11-22 | 2022-01-17 | CL BioSciences LLC | Antagoniści gastryny (eg yf476, netazepid) do leczenia i zapobiegania osteoporozie |
| KR102161674B1 (ko) * | 2014-02-18 | 2020-10-05 | 주식회사 대웅제약 | 이사틴 유도체 및 이의 제조방법 |
| CN113456631B (zh) * | 2021-08-06 | 2022-06-21 | 徐州医科大学 | 一种靶向acsl1的小分子药物及其在治疗子宫内膜癌中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4820834A (en) * | 1984-06-26 | 1989-04-11 | Merck & Co., Inc. | Benzodiazepine analogs |
| JPS62228072A (ja) * | 1985-12-20 | 1987-10-06 | Kissei Pharmaceut Co Ltd | ３−アミノインドリン−２−オン誘導体 |
| JPS62234080A (ja) * | 1985-12-20 | 1987-10-14 | Kissei Pharmaceut Co Ltd | インドリン−２−オン誘導体 |
| US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
| JPS62270576A (ja) * | 1986-05-19 | 1987-11-24 | Kissei Pharmaceut Co Ltd | イサチン誘導体 |
| JPS63156771A (ja) * | 1986-12-19 | 1988-06-29 | Kissei Pharmaceut Co Ltd | ３−アミノインドリン−２−オン誘導体 |
| JPS62156771A (ja) * | 1986-12-19 | 1987-07-11 | Tokyo Shokai:Kk | 処方箋処理装置 |
| US4876259A (en) * | 1987-01-05 | 1989-10-24 | E. I. Du Pont De Nemours And Company | 3,3-disubstituted indolines |
| EP0442878A4 (en) * | 1988-04-05 | 1991-10-23 | Abbott Laboratories | Derivatives of tryptophan as cck antagonists |
| JP3356431B2 (ja) * | 1990-08-31 | 2002-12-16 | ワーナー―ランバート・コンパニー | Ｃｃｋアンタゴニストに対するプロ―ドラッグ |
| WO1992007830A2 (en) * | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
| CA2055094A1 (en) * | 1990-11-13 | 1992-05-14 | Mark G. Bock | Cholecystokinin antagonist |
| JPH05104510A (ja) * | 1991-10-18 | 1993-04-27 | Inax Corp | 基板へのモルタル塗布方法 |
-
1994
- 1994-02-16 JP JP05654194A patent/JP3419539B2/ja not_active Expired - Fee Related
- 1994-02-16 MY MYPI94000344A patent/MY128102A/en unknown
- 1994-02-16 TW TW083101206A patent/TW281669B/zh active
- 1994-02-17 PL PL94310168A patent/PL176710B1/pl not_active IP Right Cessation
- 1994-02-17 HU HU9502415A patent/HUT74105A/hu unknown
- 1994-02-17 ES ES94907058T patent/ES2176236T3/es not_active Expired - Lifetime
- 1994-02-17 KR KR1019950703395A patent/KR100226310B1/ko not_active IP Right Cessation
- 1994-02-17 CN CN94191205A patent/CN1046268C/zh not_active Expired - Fee Related
- 1994-02-17 DE DE69430664T patent/DE69430664T2/de not_active Expired - Fee Related
- 1994-02-17 AT AT94907058T patent/ATE217864T1/de not_active IP Right Cessation
- 1994-02-17 CZ CZ19952096A patent/CZ290504B6/cs not_active IP Right Cessation
- 1994-02-17 CA CA002156287A patent/CA2156287C/en not_active Expired - Fee Related
- 1994-02-17 RU RU95120168A patent/RU2128170C1/ru not_active IP Right Cessation
- 1994-02-17 EP EP94907058A patent/EP0685463B1/en not_active Expired - Lifetime
- 1994-02-17 AU AU60448/94A patent/AU6044894A/en not_active Abandoned
- 1994-02-17 WO PCT/JP1994/000235 patent/WO1994019322A1/ja active IP Right Grant
-
1995
- 1995-08-16 FI FI953866A patent/FI112652B/fi active
- 1995-08-17 NO NO953235A patent/NO305201B1/no unknown
-
1997
- 1997-11-03 US US08/963,547 patent/US5952511A/en not_active Expired - Fee Related
-
1998
- 1998-10-30 US US09/182,491 patent/US6127544A/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,490 patent/US6207836B1/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,463 patent/US6114536A/en not_active Expired - Fee Related
- 1998-10-30 US US09/182,638 patent/US6031111A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100226310B1 (ko) | 인돌린-2-온 유도체 | |
| AU2005224129B2 (en) | Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same | |
| US5346907A (en) | Amino acid analog CCK antagonists | |
| EP1105376B1 (en) | Oxindole derivatives as growth hormone releasers | |
| WO2006080574A1 (ja) | １，３－ジヒドロ－２ｈ－インドール－２－オン化合物、及び芳香族複素環が縮合したピロリジン－２－オン化合物 | |
| KR101176675B1 (ko) | 테트라히드로이소퀴놀린 술폰아미드 유도체, 이의 제조, 및치료에서의 이의 용도 | |
| JP2006517199A (ja) | アミド誘導体およびそれらの１１−ベータ−ヒドロキシステロイドデヒドロゲナーゼ・タイプ１の阻害剤としての使用 | |
| KR19980702972A (ko) | 5-ht4 길항 활성을 갖는 이치환된 1,4-피페리딘 에스테르 및 아미드 | |
| AU2005251979B2 (en) | LXR receptor modulators | |
| US20040167119A1 (en) | 2-(aminomethyl) arylamide analgesics | |
| CA2085656A1 (en) | Benzodiazepine derivatives, compositions containing them and their use in therapy | |
| PT1668985E (pt) | Ecteinascidinas e n-óxidos de ecteinascidinas com substituições nucleofílicas | |
| WO2004041782A1 (en) | Indoles useful in the treatment of androgen-receptor related diseases | |
| JPH08505120A (ja) | ベンゾジアゼピン誘導体 | |
| WO1998049144A1 (fr) | Nouveau derive de dihydropyridine | |
| EP2261206A1 (en) | Indolinone compound | |
| GB2126230A (en) | Substituted 1-pyridyloxy-3- indolylakylamino-2-propanols, preparation, and use thereof | |
| MXPA06009346A (en) | Novel azabicyclic derivatives, preparation method thereof and pharmaceutical compositions containing same | |
| SI8910306A (sl) | Indolni derivati |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| FPAY | Annual fee payment |
Payment date: 20060616 Year of fee payment: 8 |
|
| LAPS | Lapse due to unpaid annual fee |